NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 active_not_recruiting NCT05836584
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer treatment 2 recruiting NCT06123338
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer treatment 2 recruiting NCT06549816
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors treatment 1 recruiting NCT03161522
Chemotherapy with or Without Radiation or Surgery in Treating Participants with Oligometastatic Esophageal or Gastric Cancer treatment 2 recruiting NCT04430738
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers treatment 1 / 2 active_not_recruiting NCT05365581
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer treatment 1 recruiting NCT04535414
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers No drug interventions diagnostic 2 active_not_recruiting NCT05002127
A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06) treatment 2 / 3 recruiting NCT05038098
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer diagnostic 1 not_yet_recruiting NCT05902988
A Phase I/II Study of VLS-1488 in Subjects with Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI treatment 2 recruiting NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06586294
A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma treatment 1 / 2 not_yet_recruiting NCT06614439
PG Versus TG for Advanced PGC No drug interventions treatment Not Available active_not_recruiting NCT02680990
Resilience and Exercise in Advanced Cancer Treatment No drug interventions treatment Not Available completed NCT02448290
Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy treatment 2 completed NCT00073502
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer treatment 2 completed NCT04739202
Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) treatment 2 unknown_status NCT04764084
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors treatment 1 unknown_status NCT00209079
Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma treatment 2 terminated NCT05076279
Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) No drug interventions treatment Not Available recruiting NCT06370143
A Study Collecting Health Information to Understand and Prevent Gastric Cancer No drug interventions Not Available Not Available recruiting NCT05034887
Phase 2 Study of T-DXd in the Neoadjuvant Treatment for Patients With HER2 Positive Gastric and GEJ Adenocarcinoma treatment 2 recruiting NCT05177133
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) treatment 2 recruiting NCT06206733
ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma treatment 3 recruiting NCT00352833
Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma treatment 2 completed NCT03691454
Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. treatment 2 / 3 unknown_status NCT04779151
Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab treatment 2 suspended NCT00411151
Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer treatment 2 completed NCT03852251
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma treatment 1 / 2 completed NCT04047953
Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma treatment Not Available recruiting NCT02898077
A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer treatment 3 completed NCT04517747
Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal Junction treatment Not Available completed NCT02891447
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer treatment 2 completed NCT06118645
Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance treatment 2 not_yet_recruiting NCT04190745
Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study treatment 2 unknown_status NCT03507998
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors treatment 1 unknown_status NCT02370498
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) treatment 3 completed NCT05977998
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology treatment 2 recruiting NCT05056805
An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study No drug interventions supportive_care Not Available withdrawn NCT05296005
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers treatment 1 not_yet_recruiting NCT06196697
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer treatment 2 recruiting NCT04675983
A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) treatment 3 terminated NCT01583361
SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer treatment 3 unknown_status NCT02335411
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) treatment 2 completed NCT01558011
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study treatment 2 terminated NCT00183911
Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma treatment 2 completed NCT03959293
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma treatment 2 active_not_recruiting NCT03399071
Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer treatment 2 active_not_recruiting NCT01757171
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma treatment 2 completed NCT01565109
NESC: Neoadjuvant Treatment Of Gastric Adenocarcinoma treatment 2 unknown_status NCT02638909
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies treatment 2 terminated NCT06504615
Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France Not Available Not Available not_yet_recruiting NCT03631615
Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma treatment 2 unknown_status NCT03196232
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer treatment 2 completed NCT04604132
Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma treatment 1 / 2 terminated NCT01880632
Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma No drug interventions treatment 2 unknown_status NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT06353152
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma No drug interventions treatment 1 recruiting NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT04290806
Registry Platform Gastric/Esophageal Cancer (SAPHIR) No drug interventions Not Available Not Available recruiting NCT05753306
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study treatment 2 recruiting NCT05235906
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer treatment 2 recruiting NCT05800236
Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine No drug interventions diagnostic Not Available recruiting NCT03783936
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas treatment 2 completed NCT04523818
Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma treatment 1 active_not_recruiting NCT01567618
Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer treatment 2 completed NCT02366819
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer treatment 4 recruiting NCT04499924
Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer treatment 2 / 3 completed NCT03429816
OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma No drug interventions diagnostic Not Available active_not_recruiting NCT02589496
Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis treatment 2 completed NCT02862535
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma treatment 1 terminated NCT05705635
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer treatment 2 recruiting NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancers treatment 1 / 2 recruiting NCT05816863
Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT03257163
Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer treatment 2 recruiting NCT04065139
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study No drug interventions treatment 2 suspended NCT04121039
Study of the Apatinib Combine With POF Versus POF in Gastric Cancer treatment 2 unknown_status NCT04681248
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors Not Available Not Available available NCT03122548
Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers treatment 2 terminated NCT02007148
MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer treatment 2 unknown_status NCT04162665
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer No drug interventions treatment 2 recruiting NCT06289374
Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery No drug interventions Not Available Not Available recruiting NCT00062374
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction treatment 2 completed NCT04931420
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels No drug interventions treatment 2 withdrawn NCT00667420
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma treatment 1 / 2 terminated NCT04581473
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection treatment 1 / 2 recruiting NCT02144727
A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer No drug interventions treatment 3 unknown_status NCT05311176
A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) treatment 2 active_not_recruiting NCT05001360
Study of FMT Combined With Nivolumab in Gastric Cancer treatment Not Available withdrawn NCT02830594
Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer treatment 2 completed NCT03802591
A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma treatment 3 completed NCT03365791
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies treatment 2 completed NCT01552980
Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma treatment 2 unknown_status NCT00964080
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma treatment 1 / 2 unknown_status NCT04850729
Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer. No drug interventions Not Available Not Available recruiting NCT02952989
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors treatment 1 terminated NCT06496789
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer treatment 2 recruiting NCT05319392
Transcriptomic Signatures in Gastric Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT05249244
A Real World Study of the Treatment of Gastric Adenocarcinoma With Huachansu No drug interventions Not Available Not Available unknown_status NCT03468244
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms No drug interventions treatment Not Available unknown_status NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT05394740
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy treatment 1 / 2 active_not_recruiting NCT04503967
Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer treatment 2 unknown_status NCT03739801
MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma treatment 1 / 2 withdrawn NCT04089904
Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma treatment 2 terminated NCT02545504
Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma treatment 3 completed NCT04111172
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma No drug interventions treatment 2 suspended NCT02287168
Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients No drug interventions treatment 0 completed NCT03042169
Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer No drug interventions treatment 3 unknown_status NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer treatment 1 / 2 completed NCT04161781
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer No drug interventions Not Available Not Available completed NCT06059495
Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study treatment 2 recruiting NCT05071755
Gastrectomy Outcomes in Elderly Patients No drug interventions Not Available Not Available unknown_status NCT03288350
mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA) treatment 2 unknown_status NCT03780608
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO) treatment 2 unknown_status NCT03973008
Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma No drug interventions treatment 3 recruiting NCT04074343
TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma treatment 1 completed NCT02128243
Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer treatment 2 completed NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers No drug interventions treatment 2 not_yet_recruiting NCT03735290
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer treatment 1 terminated NCT03986502
Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma No drug interventions health_services_research Not Available completed NCT06466902
Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes) No drug interventions Not Available Not Available recruiting NCT04164979
Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma treatment 2 active_not_recruiting NCT03776487
Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer treatment 2 active_not_recruiting NCT01882933
D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma treatment 3 active_not_recruiting NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas treatment 1 recruiting NCT02013154
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab treatment 1 completed NCT04034251
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis treatment 2 active_not_recruiting NCT02628951
Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis treatment 2 completed NCT02514551
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer treatment 2 completed NCT04099277
A Study of LY3435151 in Participants With Solid Tumors treatment 1 terminated NCT05135845
Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma treatment 2 suspended NCT02494583
Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) treatment 3 completed NCT05008783
A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma treatment 3 active_not_recruiting NCT01641783
Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients treatment 2 unknown_status NCT02443883
A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer treatment 2 completed NCT00848783
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers treatment 2 terminated NCT06340711
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma treatment 2 recruiting NCT03042611
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer treatment 3 completed NCT02495493
S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma No drug interventions treatment 2 completed NCT00464893
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection treatment 2 completed NCT06038578
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer treatment 2 recruiting NCT02333188
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT03686488
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma treatment 2 completed NCT01379807
Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma treatment 2 unknown_status NCT05802056
Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis treatment 1 recruiting NCT02781285
Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score No drug interventions Not Available Not Available unknown_status NCT02629315
Carnoy's Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial No drug interventions diagnostic Not Available completed NCT06028737
Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer treatment 2 / 3 recruiting NCT02915432
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC treatment 1 / 2 unknown_status NCT04999332
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer treatment 2 recruiting NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT03814759
Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma treatment 2 unknown_status NCT06250075
Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer No drug interventions treatment Not Available completed NCT03195699
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers treatment 1 active_not_recruiting NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors treatment 1 recruiting NCT04943406
Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer No drug interventions Not Available Not Available recruiting NCT04483349
Assessment of What Patients and Healthcare Providers Value No drug interventions Not Available Not Available completed NCT04114136
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies treatment 2 recruiting NCT03092518
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology treatment 2 completed NCT05723718
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment No drug interventions Not Available Not Available recruiting NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT01283217
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer treatment 3 unknown_status NCT05687617
Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma. diagnostic 2 terminated NCT03141034
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma treatment 2 completed NCT02485834
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer treatment 2 terminated NCT02443324
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer treatment 1 completed NCT03809624
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer treatment 1 active_not_recruiting NCT05482516
Evaluating Novel Therapies in ctDNA Positive GI Cancers treatment 3 recruiting NCT03246516
Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers No drug interventions prevention Not Available active_not_recruiting NCT05476796
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer treatment 2 recruiting NCT01989858
ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) No drug interventions treatment 3 terminated NCT05293535
Klotho _ LRP-6 _ Gastric Adenocarcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT06454435
Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer treatment 2 not_yet_recruiting NCT05567835
A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer treatment 2 recruiting NCT04810663
Outcome of Radiation Therapy in Operated Gastric Cancer No drug interventions Not Available Not Available unknown_status NCT04194463
Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study No drug interventions treatment Not Available unknown_status NCT05393986
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors No drug interventions treatment 1 recruiting NCT03707639
Study of the Combination of Apatinib and POF treatment 2 unknown_status NCT01794026
Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma Patients No drug interventions diagnostic 0 completed NCT05709574
Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer treatment 2 recruiting NCT03788174
Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma treatment 2 unknown_status NCT03244774
Phase I Study of the Combination of Apatinib and POF treatment 1 unknown_status NCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study No drug interventions Not Available Not Available recruiting NCT04682431
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 terminated NCT06342427
Stomach Cancer Exosome-based Detection No drug interventions Not Available Not Available completed NCT03997162
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery No drug interventions Not Available Not Available active_not_recruiting NCT01336062
Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients treatment 1 / 2 completed NCT02512380
Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer treatment 3 unknown_status NCT01932580
Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma treatment 2 completed NCT01178944
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer treatment 2 completed NCT04150640
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma treatment 2 recruiting NCT04363801
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer treatment 2 active_not_recruiting NCT04047004
Adjuvant PIPAC in Gastric Cancer Patients other 1 completed NCT04032704
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors treatment 2 terminated NCT04773769
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas No drug interventions treatment Not Available unknown_status NCT01129310
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. treatment 2 completed NCT02864381
Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma treatment 2 completed NCT04344795
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT02801955
Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma No drug interventions Not Available Not Available completed NCT03024450
Trastuzumab Based Therapy in HER2 Positive AGC Not Available Not Available completed NCT03413397
Lenvatinib Mesylate and Pembrolizumab in Treating Patients With Metastatic or Recurrent Gastric or Gastroesophageal Cancer treatment 2 recruiting NCT03368196
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein treatment 1 completed NCT05071053
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer treatment 2 active_not_recruiting NCT03409848
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma treatment 2 completed NCT04171141
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. No drug interventions treatment 1 terminated NCT06646783
Phase IIT Trial of SNA014 No drug interventions diagnostic 0 not_yet_recruiting NCT05715931
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma treatment 2 recruiting NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT03966118
Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma treatment 2 unknown_status NCT01962519
Early Oral Feeding After Total Gastrectomy for Cancer No drug interventions Not Available Not Available unknown_status NCT05315830
A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric No drug interventions treatment 1 unknown_status NCT01095120
Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer treatment 2 unknown_status NCT02678182
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial treatment 2 recruiting NCT00871273
Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma basic_science 4 terminated NCT01472029
Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach treatment 2 completed NCT00982592
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer treatment 2 completed NCT03647969
Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer treatment 2 completed NCT01561014
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction treatment 1 completed NCT04878783
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG No drug interventions Not Available Not Available active_not_recruiting NCT05872685
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) treatment 2 recruiting NCT06121700
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer treatment 2 recruiting NCT02202759
A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction treatment 2 terminated NCT01640782
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach treatment 3 completed NCT05970627
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma treatment 2 not_yet_recruiting NCT00098527
FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer treatment 2 terminated NCT00607594
Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer treatment 2 completed NCT05729646
Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma treatment 2 recruiting NCT04077255
EGFR-targeted Therapy for Gastric Cancer treatment 2 recruiting NCT03722108
Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas treatment 1 / 2 terminated NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT03791268
General Tissue Response Classification System After Chemotherapy No drug interventions Not Available Not Available unknown_status NCT06362070
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy No drug interventions treatment Not Available recruiting NCT04263870
Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction treatment 2 unknown_status NCT03982173
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors treatment 2 withdrawn NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT02564367
Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction treatment 1 / 2 completed NCT04704934
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) treatment 3 recruiting